Pharmaxis well funded as potential partners assess its anti‐fibrotic mechanisms
Zelda Therapeutics on track to report on multiple clinical trials
G Medical Innovations Holdings Ltd on track for revenue growth in 2019
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.